C C Leung
Overview
Explore the profile of C C Leung including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
947
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Leung E, Yew W, Leung C, Leung W, Tam C
Eur Respir J
. 2011 Jul;
38(1):227-30.
PMID: 21719503
No abstract available.
22.
Lo A, Huang Y, Lam S, Cheung A, Au R, Leung C, et al.
Int J Tuberc Lung Dis
. 2011 Mar;
15(4):523-7.
PMID: 21396213
Background: Smokers with silicosis are at increased risk of lung cancer. Objective: To evaluate the feasibility of using autofluorescence bronchoscopy after sputum examination for early detection of large airway lung...
23.
Leung E, Leung C, Leung W, Kam K, Yew W, Lee S, et al.
Int J Tuberc Lung Dis
. 2010 Dec;
14(12):1564-70.
PMID: 21144241
Setting: Hong Kong Chest Clinics. Objectives And Methods: To conduct a prospective study investigating the role of a whole-blood interferon-gamma release assay, QuantiFERON®-TB Gold In-Tube (QFT-GIT), in the diagnosis of...
24.
Yew W, Lange C, Leung C
Eur Respir J
. 2010 Sep;
37(2):441-62.
PMID: 20847074
Currently, the standard short-course chemotherapy for tuberculosis comprises a 6-month regimen, with a four-drug intensive phase and a two-drug continuation phase. Alternative chemotherapy using more costly and toxic drugs, often...
25.
Leung C, Rieder H, Lange C, Yew W
Eur Respir J
. 2010 Aug;
37(3):690-711.
PMID: 20693257
Much remains unknown about latent infection with Mycobacterium tuberculosis. Existing immunodiagnostic tools for this condition have various limitations, most importantly in their ability to predict disease. Randomised controlled trials have...
26.
Chan C, Alvarez Bognar F, Wong K, Leung C, Tam C, Chan K, et al.
Hong Kong Med J
. 2010 Jun;
16(3):192-8.
PMID: 20519755
Objective: To evaluate the epidemiology and clinical manifestations of human immunodeficiency virus-associated tuberculosis in Hong Kong. Design: Retrospective study. Setting: Tuberculosis and Chest Service and Special Preventive Programme, Public Health...
27.
Pang P, Leung C, Lee S
Int J Tuberc Lung Dis
. 2010 Apr;
14(5):585-92.
PMID: 20392351
Background: Tuberculosis (TB) has been reported to be associated with poverty, especially in developing countries. Hong Kong is one of the few industrialised areas with a high incidence of TB...
28.
van Zyl Smit R, Pai M, Yew W, Leung C, Zumla A, Bateman E, et al.
Eur Respir J
. 2010 Jan;
35(1):27-33.
PMID: 20044459
Tuberculosis (TB), smoking, HIV and chronic obstructive pulmonary disease (COPD) are burgeoning epidemics in developing countries. The link between TB and HIV is well established. Less well recognised is the...
29.
Chang K, Leung C, Yew W, Lau T, Leung W, Tam C, et al.
Eur Respir J
. 2009 Sep;
35(3):606-13.
PMID: 19717477
Possible masking of tuberculosis (TB) in treatment of community-acquired respiratory infection by newer fluoroquinolones has not been examined in randomised controlled trials. We undertook a randomised, open-label controlled trial involving...
30.
Analyses of fluoroquinolones and Clostridium difficile-associated diarrhoea in tuberculosis patients
Chang K, Leung C, Yew W, Lam F, Ho P, Chau C, et al.
Int J Tuberc Lung Dis
. 2009 Mar;
13(3):341-6.
PMID: 19275794
Setting: Systematic studies of fluoroquinolones (FQs) and Clostridium difficile-associated diarrhoea (CDAD) are scarce among tuberculosis (TB) patients, in whom fluoroquinolones (FQs) are increasingly used. Objective: To evaluate the relationship between...